✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Panacea Biotec Ltd.

PANACEABIO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹2,463 Cr.
P/E
214.56

Panacea Biotec Ltd.

  • Panacea Biotec
  • Indoco Remedies
  • Novartis
  • TJI Pharma - Small Cap

FAQs on Panacea Biotec Ltd. Shareprice

Panacea Biotec has given lower returns compared to its competitors.
Panacea Biotec has grown at ~13.16% over the last 7yrs while peers have grown at a median rate of 14.09%

Panacea Biotec is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Panacea Biotec is 214, while 3 year average PE is 13.99.
Also latest EV/EBITDA of Panacea Biotec is 0.0 while 3yr average is 19.58.

View FAQ's On Business

Growth Table

  • Panacea Biotec Ltd.
  • Indoco Remedies
  • Novartis

Balance Sheet

  • Panacea Biotec Ltd.
  • Indoco Remedies
  • Novartis

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Panacea Biotec Ltd.
  • Indoco Remedies
  • Novartis

Cash Flow

  • Panacea Biotec Ltd.
  • Indoco Remedies
  • Novartis

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Panacea Biotec Ltd.
  • Indoco Remedies
  • Novartis

Quarterly Results

  • Panacea Biotec Ltd.
  • Indoco Remedies
  • Novartis

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Panacea Biotec Ltd. Financials

Balance sheet of Panacea Biotec is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Panacea Biotec is increasing.
Latest net debt of Panacea Biotec is -₹191.67 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹222.98 Crs.

The profit is oscillating.
The profit of Panacea Biotec is ₹11.12 Crs for TTM, -₹8.37 Crs for Mar 2025 and -₹1.17 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Panacea Biotec latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech